Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology
Annals of Oncology2011Vol. 23(7), pp. 1730–1738
Citations Over TimeTop 10% of 2011 papers
Shadia I. Jalal, Heather Riggs, A. Melnyk, Donald Richards, Anuj K. Agarwala, M. Neubauer, Rafat Ansari, Ramaswamy Govindan, Daniel Bruetman, William B. Fisher, T. Breen, Cynthia S. Johnson, Menggang Yu, Lawrence H. Einhorn, Nasser H. Hanna
Related Papers
- Docetaxel (Taxotere): preclinical and general clinical information.(1999)
- → Ototoxicity in patients with invasive ductal breast cancer who were treated with docetaxel: report of two cases(2020)12 cited
- → The plinabulin/docetaxel combination to mitigate the known safety concerns of docetaxel.(2016)3 cited
- → Docetaxel (Taxotere) in the Treatment of Non-Small Cell Lung Cancer(2002)18 cited
- TS-1 による術後補助療法中に発症しWeekly Docetaxel 療法により著効をみた胃癌腹膜播種の1 例(2005)